Equities

Cannabis Global, Inc.

CBGL:PKC

Cannabis Global, Inc.

Actions
  • Price (USD)0.0001
  • Today's Change0.00 / 0.00%
  • Shares traded154.80k
  • 1 Year change-84.85%
  • Beta1.7305
Data delayed at least 15 minutes, as of Jun 14 2024 17:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cannabis Global, Inc. manufactures and distributes various cannabis products through its ownership of Natural Plant Extract, Inc. The Company is engaged in developing the Ethos Comply Bag and conducts research and development in the areas of hemp, cannabis, and consumer food goods. It operates and manages Natural Plant Extract of California, Inc. (NPE) which holds two active California cannabis licenses: a Type 7 manufacturing license and a distribution license. These licenses allow NPE to distribute cannabis products in the State of California. These products included several types of cannabis products, including Cannabis flower packaged in various weights, which are sold to California licensed cannabis retailers and distributors; cannabis pre-rolls, which are sold to California licensed cannabis retailers and distributors, and cannabis edible products, which are sold to California licensed cannabis retailers and distributors.

  • Revenue in USD (TTM)2.62m
  • Net income in USD-3.16m
  • Incorporated2020
  • Employees3.00
  • Location
    Cannabis Global, Inc.520 S. Grand Avenue, Suite 320LOS ANGELES 90071United StatesUSA
  • Phone+1 (310) 986-4929
  • Websitehttps://cannabisglobalinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Limitless Venture Group Inc0.00-10.68m253.92k-----------117.82-117.820.00-9.89---------------------------37.95----------------
Bioquest Corp0.00-507.41k260.72k-----------0.0485-0.04850.00-0.04670.00-------3,483.76-----------------3.88--------64.67------
Propanc Biopharma Inc0.00-2.46m268.77k1.00---------0.3033-0.30330.00-0.03370.00-------2,440.90-4,945.87---------------1.70---------17.63------
Endonovo Therapeutics Inc255.72k-4.40m279.52k0.00------1.09-0.0652-0.06520.0003-0.0720.2256-------388.54-303.26----96.2174.38-1,722.26-5,956.27---1.38----85.15---495.02------
Athersys Inc80.00k-37.51m282.98k24.00------3.54-2.03-2.030.004-1.360.0037--0.24243,333.33-174.57-120.93---206.72-----46,883.75-727.72---------3.437.5116.58--6.85--
CNBX Pharmaceuticals Inc540.25k-1.23m292.45k2.00------0.5413-0.0583-0.05830.0237-0.07581.73----270,125.00-393.70-73.32---99.806.37---228.08-3,970.88---1.37------111.900.3497------
Acorda Therapeutics Inc115.66m-263.43m310.52k102.00------0.0027-212.10-212.1093.13-149.560.50681.1412.591,133,961.00-115.42-26.62-266.35-31.9786.3878.22-227.75-111.910.1533-0.69233.57---0.7869-24.24-283.60---62.13--
DMK Pharmaceuticals Corp3.62m-21.16m313.16k11.00------0.0865-8.69-9.181.04-0.49180.34325.665.54329,062.70-200.59-79.00---113.05-37.304.85-584.50-347.590.5355------115.34-18.3124.28---20.10--
Better Therapeutics Inc0.00-31.57m363.99k54.00---------1.16-1.160.00-0.24490.00----0.00-162.15---378.28-------------15.183.27------1.43------
Cannabis Global, Inc.2.62m-3.16m373.18k3.00--0.0172--0.1425-0.0324-0.03240.0080.00580.192914.135.92---27.77-164.57-140.92---2.45---143.95-831.070.1799-1.750.3238--5,829.78---58.94------
Life Stem Genetics Inc0.00-568.02k393.34k1.00--0.21-----0.013-0.0130.000.00760.00----0.00-198.83---330.32--------------0.0241--------------
Baudax Bio Inc310.00k-25.83m422.85k9.00------1.36-17.25-9.170.0778-0.09850.0163----34,444.45-135.61-112.14---192.87-1,445.81---8,331.61-9,179.73----1.30--17.50---164.95---56.52--
Health Advance Inc-100.00bn-100.00bn464.87k3.00--0.1182----------0.0212----------------------------0.0356--100.00---21.75------
Drazcanna Inc2.05m-5.71m477.58k--------0.2333-0.7024-0.70240.24920.10040.685--23.88---191.19---643.20---11.20---279.10-----33.040.2445--------------
Data as of Jun 14 2024. Currency figures normalised to Cannabis Global, Inc.'s reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.